Related Experiment Video
Updated: Apr 26, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
2.8K
Circulatory support for shock complicating myocardial infarction
Deepak Acharya1, Renzo Y Loyaga-Rendon, Jose A Tallaj
1Division of Cardiovascular Diseases, THT 321, 1900 University Blvd, Birmingham, AL 35294 USA. dacharya@uab.edu.
The Journal of Invasive Cardiology
|August 6, 2014
Summary
This study covers a patient with acute myocardial infarction and cardiogenic shock treated with percutaneous coronary intervention and the Impella CP device. It reviews mechanical circulatory support and management for acute myocardial infarction with cardiogenic shock.
Area of Science:
- Cardiology
- Interventional Cardiology
- Critical Care Medicine
Background:
- Acute myocardial infarction with cardiogenic shock (AMI-CS) is a critical condition with high mortality.
- Mechanical circulatory support (MCS) is increasingly utilized in managing AMI-CS.
- Percutaneous coronary intervention (PCI) is a cornerstone therapy for AMI.
Observation:
- A case of AMI-CS successfully managed with PCI and the Impella CP device is presented.
- The Impella CP is a novel, short-term, percutaneously inserted mechanical circulatory support device.
- Hemodynamic parameters were monitored during the intervention.
Findings:
- The Impella CP provided effective hemodynamic support in this AMI-CS patient.
- PCI successfully restored coronary blood flow.
- The combination of PCI and Impella CP demonstrated a viable treatment strategy.
Implications:
- This case highlights the potential benefit of the Impella CP in select AMI-CS patients.
- Further research is warranted to establish the optimal role of short-term MCS devices in AMI-CS.
- Evidence review supports the integration of MCS into AMI-CS management protocols.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
01:28Acute Coronary Syndrome IV: Interprofessional Care
519
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
519
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
01:26Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
01:14Myocarditis III: Medical Management
342
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
01:30Cardiomyopathy II: Dilated Cardiomyopathy
785
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
785